سال 10، شماره 39 - ( English 1390 )                   سال 10 شماره 39 صفحات 42-33 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noroozian M, Mohebbi-Rasa S, Tasviechi A, Sahraian M, Karamghadiri N, Akhondzadeh S. Ginkgo biloba for Improvement of Memory and Quality of Life in Multiple Sclerosis: an Open Trial. J. Med. Plants 2011; 10 (39) :33-42
URL: http://jmp.ir/article-1-199-fa.html
Noroozian M، Mohebbi-Rasa S، Tasviechi AK، Sahraian MA، Karamghadiri N، Akhondzadeh S. Ginkgo biloba for Improvement of Memory and Quality of Life in Multiple Sclerosis: an Open Trial. فصلنامه گياهان دارویی. 1390; 10 (39) :33-42

URL: http://jmp.ir/article-1-199-fa.html


1- Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences
2- Sina Hospital, Tehran University of Medical Sciences
3- Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences ، s.akhond@neda.net
چکیده:   (5015 مشاهده)
Background: Multiple sclerosis (MS) is a chronic demyelinating disease that can affect cognitive function. The purpose of this study was to assess the efficacy of Ginkgo biloba (GB) on improvement of memory impairment and quality of life in patients with MS. Methods: This study was an 8-week, open study of patients with MS. Thirty patients was recruited from a variety of outpatient settings. All participants met McDonald's diagnostic criteria for MS and had Wechsler score of<80. All subjects received Ginkgo 240 mg/day, TDS except one that received 120 mg/day, TDS due to history of gastritis Participants were assessed by Wechsler memory scale, MSIS-29 test and Beck Depression Inventory (BDI) which measure memory, quality of life and depression respectively at baseline and after 8 weeks of treatment. Results: Administration of Ginkgo significantly improved Wechsler and MSIS-29 scores. Subjects who were less impaired at baseline on the Wechsler test experienced more improvement with GB. Conclusion: The present study indicates Ginkgo biloba as a very well tolerated medication for improvement of cognitive impairments in people suffering from MS.
واژه‌های کلیدی: Ginkgo biloba، Multiple Sclerosis، Memory impairment، Wechsler test
متن کامل [PDF 175 kb]   (1857 دریافت)    
نوع مطالعه: پژوهشی | موضوع مقاله: فارماكولوژی و سم شناسی
دریافت: 1390/3/28 | پذیرش: 1390/6/12 | انتشار: 1390/6/31

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

ارسال پیام به نویسنده مسئول


بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به فصلنامه علمی پژوهشی گیاهان دارویی می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | Journal of Medicinal Plants

Designed & Developed by : Yektaweb